From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disorder. In this review, we provided a comprehensive overview of biomarkers involved in COPD, and potential novel biological therapies that may provide additional therapeutic options for COPD. The complex characteristics of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hsu-Hui Wang, Shih-Lung Cheng
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/318cf7861bd244ecafbc08260be56a74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:318cf7861bd244ecafbc08260be56a74
record_format dspace
spelling oai:doaj.org-article:318cf7861bd244ecafbc08260be56a742021-11-25T16:49:56ZFrom Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease10.3390/biomedicines91116382227-9059https://doaj.org/article/318cf7861bd244ecafbc08260be56a742021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1638https://doaj.org/toc/2227-9059Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disorder. In this review, we provided a comprehensive overview of biomarkers involved in COPD, and potential novel biological therapies that may provide additional therapeutic options for COPD. The complex characteristics of COPD have made the recommendation of a generalized therapy challenging, suggesting that a tailored, personalized strategy may lead to better outcomes. Existing and unmet needs for COPD treatment support the continued development of biological therapies, including additional investigations into the potential clinical applications of this approach.Hsu-Hui WangShih-Lung ChengMDPI AGarticlechronic obstructive pulmonary diseasebiomarkerstherapeutic approachesbiologicsBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1638, p 1638 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic obstructive pulmonary disease
biomarkers
therapeutic approaches
biologics
Biology (General)
QH301-705.5
spellingShingle chronic obstructive pulmonary disease
biomarkers
therapeutic approaches
biologics
Biology (General)
QH301-705.5
Hsu-Hui Wang
Shih-Lung Cheng
From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
description Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disorder. In this review, we provided a comprehensive overview of biomarkers involved in COPD, and potential novel biological therapies that may provide additional therapeutic options for COPD. The complex characteristics of COPD have made the recommendation of a generalized therapy challenging, suggesting that a tailored, personalized strategy may lead to better outcomes. Existing and unmet needs for COPD treatment support the continued development of biological therapies, including additional investigations into the potential clinical applications of this approach.
format article
author Hsu-Hui Wang
Shih-Lung Cheng
author_facet Hsu-Hui Wang
Shih-Lung Cheng
author_sort Hsu-Hui Wang
title From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
title_short From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
title_full From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
title_fullStr From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
title_full_unstemmed From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
title_sort from biomarkers to novel therapeutic approaches in chronic obstructive pulmonary disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/318cf7861bd244ecafbc08260be56a74
work_keys_str_mv AT hsuhuiwang frombiomarkerstonoveltherapeuticapproachesinchronicobstructivepulmonarydisease
AT shihlungcheng frombiomarkerstonoveltherapeuticapproachesinchronicobstructivepulmonarydisease
_version_ 1718412885699330048